Clinical Trials · NCT01153425

µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Pennsylvania
Enrollment
33
Start date
Jul 2008
Locations
1 site, United States
Primary endpoint
Percentage of Change in Trabecular Surface-to-curve Ratio
View Teriparatide compound reference